Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Frequently asked questions
What sector does SDZNY (SDZNY) operate in?
SDZNY belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is SDZNY (SDZNY) current stock price?
As of the latest data, SDZNY stock price is $90.66, with a previous close of $89.27. SDZNY gained $1.39 in the last trading session, representing a 1.56% increase.
What is SDZNY (SDZNY) current market capitalization?
SDZNY market cap is approximately 39.23 billion.
What is SDZNY (SDZNY) Earnings Per Share (EPS)?
The trailing EPS is $1.45, and the forward EPS is $4.64.
What is SDZNY (SDZNY) Price-to-Earnings (P/E) ratio?
SDZNY current P/E ratio is 62.52, with a forward P/E of 19.54.
Does SDZNY (SDZNY) pay dividends?
Yes. SDZNY pays annual dividends with an annualized yield of 1.13% and an estimated annual payout of $1.03 per share.
When is the next ex-dividend date for SDZNY (SDZNY)?
The next ex-dividend date is scheduled for April 14, 2027.
What is SDZNY (SDZNY) beta (volatility) score?
SDZNY has a beta of 0.492, indicating lower volatility than the overall market.
